Cover art for Let's Talk Risk! Podcast

Deep Dive

Let's Talk Risk! Podcast

Deep Dive: When FDA Qualifies the Ruler

Published
September 18, 2026
Duration
19:43
Summary source
description
Last updated
Sep 30, 2026

Discusses A qualified tool does not eliminate regulatory scrutiny. It eliminates the need to keep proving that…

Summary

A qualified tool does not eliminate regulatory scrutiny. It eliminates the need to keep proving that the same ruler works.What if one of the biggest sources of friction in medical device development is not the device itself—but the tool being used to measure its performance?Historically, FDA evaluated many of these tools as part of individual device submi…

Intelligent Report

Sign in to read teasers, or upgrade to Research Pro to commission intelligent report for this episode. Learn more →

Show notes

A qualified tool does not eliminate regulatory scrutiny. It eliminates the need to keep proving that the same ruler works.What if one of the biggest sources of friction in medical device development is not the device itself—but the tool being used to measure its performance?Historically, FDA evaluated many of these tools as part of individual device submissions. The Medical Device Development Tools (MDDT) program creates a different pathway: qualify a tool for a defined context of use, and spons

Deep Dive: Deep Dive: When FDA Qualifies the Ruler | Let's Talk Risk! Podcast | Vagelintel